Peter D Burbelo Selected Research

Critical Care (Surgical Intensive Care)

1/2021	SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.
10/2010	Rapid induction of autoantibodies during ARDS and septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter D Burbelo Research Topics

Disease

33	Infections 11/2023 - 07/2008
20	COVID-19 12/2023 - 01/2020
13	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2010
7	Neoplasms (Cancer) 01/2022 - 08/2005
6	Pneumonia (Pneumonitis) 01/2023 - 01/2019
6	Inflammation (Inflammations) 12/2022 - 10/2010
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2012
5	Opportunistic Infections (Opportunistic Infection) 01/2019 - 12/2010
4	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2023 - 08/2016
4	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2013 - 05/2009
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2023 - 03/2014
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023 - 01/2017
3	Human Influenza (Influenza) 12/2021 - 08/2009
3	Disease Progression 01/2021 - 09/2014
3	Communicable Diseases (Infectious Diseases) 10/2017 - 06/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2015 - 09/2008
2	Hepatitis 01/2023 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 09/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 12/2021 - 05/2016
2	Cough 07/2021 - 03/2021
2	Fever (Fevers) 07/2021 - 03/2021
2	Viremia 01/2019 - 05/2012
2	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 10/2016
2	Persistent Infection 01/2018 - 02/2015
2	Kidney Diseases (Kidney Disease) 01/2017 - 07/2015
2	Epstein-Barr Virus Infections 04/2016 - 10/2011
2	Autistic Disorder (Autism) 12/2015 - 07/2013
2	Sjogren's Syndrome (Sjogren Syndrome) 09/2014 - 09/2009
2	Lyme Disease (Disease, Lyme) 09/2011 - 06/2010
2	Myasthenia Gravis 03/2011 - 12/2010
1	Fatigue 02/2024
1	Severe Acute Respiratory Syndrome 10/2023
1	Contracture 01/2023
1	Lung Injury 01/2023
1	Muscular Diseases (Myopathy) 01/2023
1	Cytokine Release Syndrome 09/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	COVID-19 related pediatric multisystem inflammatory disease 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Gastritis 01/2022
1	Reinfection 12/2021
1	Thymoma (Thymic Carcinoma) 11/2021
1	Encephalitis (Encephalitis, Rasmussen) 10/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	type 1 Autoimmune polyendocrinopathy syndrome 01/2021

Drug/Important Bio-Agent (IBA)

34	AutoantibodiesIBA 01/2023 - 02/2008
31	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
28	AntibodiesIBA 12/2023 - 08/2005
18	LuciferasesIBA 01/2020 - 02/2008
17	AntigensIBA 12/2023 - 07/2008
12	AutoantigensIBA 01/2022 - 09/2008
10	VaccinesIBA 01/2023 - 03/2009
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2008
6	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2009
6	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2009
5	InterferonsIBA 12/2023 - 08/2012
5	CytokinesIBA 01/2021 - 12/2010
4	EpitopesIBA 12/2023 - 03/2011
4	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2011
3	Messenger RNA (mRNA)IBA 12/2023 - 09/2014
3	mRNA VaccinesIBA 12/2023 - 11/2021
3	Neutralizing AntibodiesIBA 10/2021 - 10/2009
3	Immunoglobulin G (IgG)IBA 03/2021 - 07/2008
3	Nucleocapsid ProteinsIBA 01/2021 - 01/2020
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 07/2015
3	Recombinant ProteinsIBA 01/2020 - 11/2013
2	Interferon Type IIBA 12/2023 - 01/2021
2	Monoclonal AntibodiesIBA 10/2023 - 01/2021
2	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 03/2014
2	Insulin (Novolin)FDA Link 01/2022 - 01/2012
2	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 01/2015
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Phospholipase A2 ReceptorsIBA 01/2020 - 01/2017
2	EnzymesIBA 04/2016 - 02/2015
2	Glutamic Acid (Glutamate)FDA Link 12/2015 - 02/2008
2	Indicators and Reagents (Reagents)IBA 09/2015 - 05/2009
2	Viral RNAIBA 02/2015 - 10/2011
2	CyclinsIBA 05/2013 - 05/2009
1	catechol (pyrocatechol)IBA 02/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	ProteomeIBA 12/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2023
1	NucleotidesIBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	ThrombospondinsIBA 01/2023
1	blinatumomabIBA 09/2022
1	Chimeric Antigen ReceptorsIBA 09/2022
1	tisagenlecleucelIBA 09/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2021
1	InterleukinsIBA 01/2021

Therapy/Procedure

7	Therapeutics 11/2023 - 11/2012
2	Critical Care (Surgical Intensive Care) 01/2021 - 10/2010
2	Immunomodulation 01/2019 - 12/2018
1	Lung Transplantation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2021